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Background: We investigated the use of a simple novel nut and bolt task in premanifest and 
manifest Huntington’s disease (HD) patients to detect and quantify motor impairments at all stages 
of the disease.
Methods: Premanifest HD (n=24), manifest HD (n=27) and control (n=32) participants were asked 
to screw a nut onto a bolt in one direction, using three different sized bolts with their left and right 
hand in turn.
Results: We identified some impairments at all stages of HD and in the premanifest individuals, 
deficits in the non-dominant hand correlated with disease burden scores.
Conclusion: This simple, cheap motor task was able to detect motor impairments in both 
premanifest and manifest HD and as such might be a useful quantifiable measure of motor function 
for use in clinical studies.
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Huntington’s disease (HD) is an autosomal dominant condition causing neurodegeneration of the 
cortex  white matter  and basal ganglia . This leads clinically to motor deficits including chorea, 
bradykinesia, and dystonia as well as cognitive deficits, circadian rhythm disturbances and 
psychiatric problems . The ability to robustly detect early motor impairments in HD using a simple 
cheap test is needed to provide an objective quantifiable measure of motor performance that is 
useful both clinically and as an endpoint in therapeutic trials, and which can be followed over time. 
Also more tests that measure everyday motor tasks that impact on functional independence as the 
disease progresses are required. As such, many groups, including our own, have sought to develop 
motor tasks to detect and track early changes in premanifest HD (preHD)  including both the 
finger  and hand tapping tests  Motor differences are not just seen in tapping tasks, as 
other studies have shown that there are changes in the variability of grip force in a grasping task in 
HD patients ; a reduction in tongue force in preHD patients ; a reduction of speech rate in motor 
speech tasks  and impairments in saccade latency and velocity in HD . Furthermore these 
simple tasks have been correlated to structural brain changes in HD and preHD  as well as 
cognitive deficits . Other more complex motor tasks such as those involving diadochokinetic 
movements  and peg insertions, whilst able to detect impairments in manifest disease are 
insensitive during preHD . Many of these tasks described require specialized equipment and 
complicated analysis. In this paper we have assessed participants with manifest HD and preHD 
Funding Statement
INTRODUCTION
1 2,3 4,5
6,7
8,9
8,9 10,11,12,13
14 15
16 12,17
18
19
20
21
Page 2 of 14Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Hunt...
06/12/2016http://currents.plos.org/hd/article/novel-nut-and-bolt-task-quantifies-motor-deficits-in-...
using a very simple and cheap nut and bolt test which has previously been used to look at the 
effects of extravehicular activity (EVA) gloves on dexterity, grip force and coordination in healthy 
participants . This new test is ideal for use in HD given its ecological validity, its ease of 
administration and the fact that it is so inexpensive; this makes it accessible for use in any 
population of HD patients and it doesn’t require any specialised custom computer software to 
interpret the results collected. To examine the validity of this new motor task, we tested a large 
group of individuals at pre-manifest and manifest stages of HD compared to healthy controls. 
Finally, we examined whether performance on this timed nut and bolt test was related to disease 
burden score (DBS). We now report for the first time that this simple inexpensive test can detect the 
earliest motor abnormalities in HD and performance correlates with disease burden scores across 
the entire disease, and so could be used to target those patients on the cusp of developing overt 
disease and as such may be suitable for use in new trials of disease modifying therapy.
Participants
Participants were recruited from the regional NHS HD clinic at the John Van Geest Centre for Brain 
Repair between 2012 and 2014. Control subjects with no known neurological disease were 
recruited from friends or relatives accompanying patients to the clinic. Written informed consent was 
taken and the nut and bolt data was collected under ethical approval [Reference 
number:09/H0308/2] approved by Cambridgeshire 2 Research Ethics Committee. To collect 
additional data the task was also expanded to include patients seen in clinic as part of their routine 
clinical assessment and the collection of this data was classified as a service evaluation with the 
Patient Safety Unit at Addenbrooke’s Hospital (Project Register Number: 4256). The work was 
carried out in accordance with the World Medical Association Declaration of Helsinki . All preHD 
and HD participants had a positive genetic test for the HD mutation and were assessed using the 
UHDRS motor examination along with their total functional capacity (TFC) sub-section . PreHD 
participants were defined by having a diagnostic confidence level on the UHDRS of less than 4. 
Disease burden score was calculated using the CAG-Age Product Scale (CAPS) .
Nut and bolt task
The nut and bolt task was designed as a simple test to examine dexterity of the hands and fingers. 
The participants were asked to screw a nut onto a bolt in one direction using either the left or right 
hand; participants were not allowed to flick the nut and the hand holding the bolt had to remain 
static/stationary. The task consisted of 3 different sized nuts and bolts and was timed for both hands 
for all conditions. The task was performed using two test conditions; while the hands were 
supported resting on a table or unsupported, with the hands held in mid air. The task was timed 
using a standard stopwatch, the timer was started when the participant began screwing the nut onto 
the bolt and the timer was stopped when the nut reached the top of the bolt and could go no further. 
All those administering this test were instructed in how to carry out the test, but the simplicity of the 
task and the use of a simple stopwatch meant that no extensive training was needed.
Statistics
Statistical analysis was performed using IBM SPSS software version 21.0. The main outcome for 
the task was the time it took for each participant to screw the nut onto the bolt using the left and 
right hand sequentially, both supported and unsupported. The independent variables were the three 
groups (Controls, PreHD, HD). Normality for all the dependent variables was tested using one-
sample Kolmogorov-Smirnov tests. Group effects for variables that were normally distributed, such 
22
METHODS
23
24
25,26
Page 3 of 14Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Hunt...
06/12/2016http://currents.plos.org/hd/article/novel-nut-and-bolt-task-quantifies-motor-deficits-in-...
as age, CAG repeat, and UHDRS motor score were analysed using parametric tests (ANOVA) 
followed by post-hoc comparisons (T-test) with Bonferroni corrections where significance was 
present, all p values reported in the manuscript are already corrected. The group main effect was 
found to be significant. Variables with a skewed distribution, including data obtained from the nut 
and bolt assessments were first logarithmically transformed to obtain normality and analysed as 
above with the exception of the total functional capacity scores which were analysed using Mann-
Whitney U tests. Partial Spearman correlations were performed using age as a covariate.
Participant demographics
A total of 83 participants were tested on this task and were divided into 3 groups: healthy controls, 
preHD and manifest HD participants (See table 1). As would be expected, manifest HD participants 
had a higher UHDRS total score [p < 0.001] and a lower TFC score [p < 0.001] than preHD 
participants. Healthy controls and preHD participants displayed similar baseline demographics (age) 
[p = 0.863], while participants with manifest HD were slightly older than control participants [p = 
0.004] (Table 1).
RESULTS
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Table 1. Table shows mean ± S.E.M. UHDRS: Unified Huntington’s Disease Rating Scale: total 
motor score, TFC: total functional capacity. *indicates statistically significant difference when 
compared to controls whereas # indicates statistically significant difference when compared to 
preHD.PreHD participants show impaired performance in their performance with the non-dominant 
hand compared to controls.
PreHD participants show impairments in their performance with the non-dominant hand 
compared to controls.
PreHD participants were impaired on several aspects of the nut and bolt task when compared to the 
healthy controls, particularly when the non-dominant hand was being tested. Significant changes 
were observed with all sizes of the nut and bolt when the non-dominant hand was in the 
unsupported condition [small: p = 0.036. medium: p = 0.006 large: p = 0.001, table 2] and the large 
nut and bolt when the non-dominant hand was supported [p = 0.034]. In contrast, only one 
measurement was significantly different when testing the dominant hand [medium, unsupported: p = 
0.009] indicating that dominant hand function is relatively well preserved at this stage of the 
condition (Table 2).
Anti-dopaminergic medication has no effect on performance on the nut and bolt task.
Anti-dopaminergic medications such as sulpiride and olanzapine are commonly used for treating the 
motor features of HD and hence may have an effect on performance in the nut and bolt task. In 
order to analyse the effect of such medications, we divided the preHD and HD participants into 
those who were receiving anti-dopaminergic medications and those who were not. Due to the 
nature of prescribing such medication for symptomatic relief of the motor features of HD, patients 
who were receiving such medication were in a more advanced stage of disease and hence were 
significantly older and a higher total motor score on the UHDRS [TMS: t = 3.29, p = 0.002, Age: t = 
2.85, p = 0.006]. Therefore in order to minimise such confounding facts we included age and the 
total motor score as covariates in our analysis. Our results showed that there was no statistically 
significant difference in motor performance between those receiving anti-dopaminergic medication 
and those who were not [F = 1.75, p > 0.111].
Table 1:Demographic and clinical characteristics of study participants.
Group Age CAG UHDRS TFC
Premanifest (n=24) 47.47 ± 2.66 41.73 ± 0.662 3.87 ± 0.975 12.26 ± 0.492
Manifest (n=27) 56.30 ± 2.62* 43.74 ± 0.796 24.07 ± 2.28# 8.78 ± 2.28#
Controls (n=32) 43.08 ± 3.18 – – –
Page 5 of 14Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Hunt...
06/12/2016http://currents.plos.org/hd/article/novel-nut-and-bolt-task-quantifies-motor-deficits-in-...
Manifest HD patients are significantly impaired in all domains of the nut and bolt task
Compared to controls the manifest group performed worse on all conditions tested while the preHD 
group appeared to demonstrate deficits under specific conditions (Table 2). In particular, whereas 
dominant hand function was not significantly different when comparing preHD to controls, manifest 
HD participants showed impairments compared to preHD when the dominant hand was tested with 
the small and medium nut and bolts whilst supported [small: p = 0.002, medium: p = 0.021] and the 
small and large nut and bolts whilst unsupported [small: p = 0.02, large: p = 0.006]. Performance 
with the small nut and bolt using the unsupported non dominant hand is significantly impaired at all 
stages of disease [preHD compared to controls: p = 0.036, HD compared to preHD: p = 0.032] 
(Figure 1) and correlates significantly with disease burden score (r=0.374), even when controlled for 
age [p = 0.021] (Figure 2). Finally all components of the nut and bolt task correlated with the 
patients UHDRS score in both preHD and manifest patients [small non-dominant unsupported nut 
and bolt: r = 0.494, p = 0.001].
Table 2: Median times for each group to complete nut and bolt task; for all task conditions
Median (Seconds) p values
Controls PreHD HD Control-
PreHD
PreHD-
HD
Controls-
HD
Non 
Dominant
Supported Small 24 29 37 0.435 0.024 <0.001
Medium 19 25 31 0.076 0.04 <0.001
Large 14.5 24 21 0.034 0.093 <0.001
Unsupported Small 19 25 36 0.036 0.032 <0.001
Medium 14.5 23 30 0.006 0.198 <0.001
Large 10 19 23.5 0.001 0.235 <0.001
Dominant Supported Small 23 25 43.5 0.152 0.002 <0.001
Medium 19.6 23 35.5 0.122 0.021 <0.001
Large 17.5 20 29 0.559 0.084 <0.01
Unsupported Small 21 22 36.5 0.239 0.02 <0.001
Medium 16.5 21 32 0.009 0.052 <0.001
Large 13 15 26.5 0.14 0.006 <0.001
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Fig. 1: Non dominant unsupported hand measurements of time to complete small nut and bolt 
test for each group.
Unsupported small nut and bolt in the non dominant hand in each group. Significance is denoted by 
asterisks, preHD compared to controls: p = 0.036, HD compared to preHD: p = 0.032.
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Fig. 2: Small nut and bolt measurement correlates with Disease Burden Score.
The time taken for the non dominant unsupported hand to complete the small nut and bolt task 
correlates with disease burden score [r = 0.374, p = 0.021]. Correlation is significant at the 0.05 level 
(2-tailed).
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The ability to detect, quantify and follow the loss of hand dexterity in HD is of importance for 
diagnosing patients at the earliest stages of disease, monitoring disease progression and evaluating 
the efficacy of novel treatments. Previous tests that have been proposed to be useful in this regard 
include finger  and hand tapping  with both tasks tracking disease course over time . 
However, while they capture changes in motor speed they do not measure changes in dexterity. In 
our new study, we introduced a novel task: the nut and bolt test, which we have now shown to be a 
useful way of measuring the impact of HD on fine motor coordination in a large group of patients. In 
particular, we have found significant differences in performance between preHD and controls in 
their non dominant hand with the dominant hand function remaining intact until later in the disease 
course. Furthermore the non dominant nut and bolt performance correlated with disease burden 
scores suggesting a relationship with proximity to disease onset. Therefore, the nut and bolt task 
may be both diagnostically useful and helpful for identifying premanifest patients at immediate risk 
of developing manifest disease who may also therefore be suitable for future trials of disease 
modifying therapy.
This finding of decreased performance in the non dominant hand is in agreement with the existing 
literature; specifically the TRACK-HD study that showed that there is a reduction in finger tapping in 
the non dominant hand over time . In the cohort of premanifest and early HD patients, it was found 
that tapping was one of the few functional measurements that had significant differences in preHD 
participants compared to controls and also progressed over time . Previously, differences in 
performance on simple speed tapping tasks in preHD and early stage HD cohorts have been 
correlated with cortical thickness, disease burden scores and motor scores  and in another study 
manifest and early HD patients tapping scores correlated with cognitive test scores, regional brain 
atrophy and UHDRS scores . All of which highlights that these simple motor measures are useful 
measures of disease stage with a pathology that can also be quantified.
Other motor tasks that have also be used in a similar way in HD include saccadic eye movements in 
which it has been shown that preHD patients can have a number of abnormalities that seem to track 
disease course over time . Quantitative measurements of tongue protrusion force in preHD and 
HD have also detected deficits in motor force  and in motor speech timing tasks in manifest HD 
patients showing impaired speech rhythm with defects in speech rate, increased pauses, impaired 
syllable repetition all of which correlated with motor tapping assessments . Other studies have 
shown slowing of rapid alternating movements in HD patients, as well as deficits in tapping and on 
peg insertion tasks . This confirms earlier findings where the peg insertion task was significantly 
different in HD patients compared to controls but failed to detect early changes in preHD groups . 
These tasks along with our simple task may suggest that the combination of speed and simple 
movements may highlight early deficits in HD, especially in the less dextrous non dominant hand. 
Indeed our nut and bolt task is unique in that is takes into account speed, dexterity, hand 
movements and motivation and as such may be more sensitive to the very earliest problems in HD 
which effects all of these functions. This would fit with imaging and post mortem data showing that 
those brain regions involved in these motor and affective activities are known to be abnormal in 
preHD and early HD including the striatum  the nucleus accumbens, pallidum  precentral and 
postcentral gyri as well as the supplementary motor area . Thus the clinical data sits well with the 
known neuropathology of premanifest and early HD.
Although, our test has many advantages including its cost and ease of administration and simple 
interpretation of results there are also some limitations with our study . This includes the absence of 
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longitudinal data, and the need to trial it in larger numbers of patients and the problems of 
employing it in very advanced patients. However, this latter group are unlikely to be the target of 
new therapeutic interventions in the first instance, so this is less of an issue. Furthermore the nut 
and bolt task was timed manually using a standard stop watch and although the timing was not 
automated, each individual was trained in the same way and thus is unlikely to have contributed to 
any significant issues on the accuracy of the data collection. However using an automated timer 
may be a useful addition to our task. Finally our study captured a selection of un-medicated and 
medicated preHD and HD patients seen in our regional clinic, including HD patients on anti-
dopaminergic medication such as sulpiride and olanzapine. Although we found no significant 
difference in our task in those patients on anti-dopaminergic medications compared to those who 
were not, we cannot rule out that this may effect their performance. In the future longitudinal studies 
that specifically address this issue are needed.
In summary, we describe a simple, inexpensive and robust task that is useful in defining disease 
onset as well as being of possible value in therapeutic trials of disease modifying therapies in both 
manifest patients and pre-HD patients approaching the time of phenoconversion. Furthermore it can 
be used in any clinic on its own or as part of a battery of tests to assess dexterity across all stages 
of HD given its simplicity and low cost.
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